Anticholinergic burden may increase costs, resource use in older adults with OAB in the UK Clinical study 21 August 2021 Pages: 1 - 1
Breast cancer screening and prevention cost effective in Europe Clinical study 21 August 2021 Pages: 2 - 2
Clean intermittent catheterisation taught to patients is cost saving for postoperative urinary retention Clinical study 21 August 2021 Pages: 3 - 3
Costs of providing COVID 19-protective measures during routine immunisation in lower-income countries? Clinical study 21 August 2021 Pages: 4 - 4
Costs of treating diabetes complications in US Medicare beneficiaries can be high Clinical study 21 August 2021 Pages: 5 - 5
Early breast screening cost effective after leukaemia or sarcoma Clinical study 21 August 2021 Pages: 7 - 7
Empagliflozin appears to be cost effective for T2DM patients with established CVD in China Clinical study 21 August 2021 Pages: 8 - 8
Fixed-combination indacaterol acetate, glycopyrronium, mometasone cost effective for adults with poorly controlled asthma in Italy Non-clinical study 21 August 2021 Pages: 9 - 9
Higher prices of newer antidiabetics drugs make them less cost effective in the USA Clinical study 21 August 2021 Pages: 11 - 11
Ibrutinib ± rituximab for MCL saves costs versus chemoimmunotherapy Clinical study 21 August 2021 Pages: 12 - 12
Long-acting monoclonal antibody likely cost-effective for preventing infant RSV in Mali Clinical study 21 August 2021 Pages: 14 - 14
Mohs micrographic surgery cost effective for stage T2a cutaneous squamous cell carcinoma Clinical study 21 August 2021 Pages: 15 - 15
Multiple myeloma: one-weekly selinexor + bortezomib + dexamethasone cost effective? Clinical study 21 August 2021 Pages: 16 - 16
Non-opioids cost effective in surgery-eligible patients with osteoarthritis? Clinical study 21 August 2021 Pages: 17 - 17
Rate of catastrophic healthcare expenditure in cancer patients Clinical study 21 August 2021 Pages: 18 - 18
Remdesivir appears to save costs in COVID-19 patients on low-flow oxygen therapy in Turkey Clinical study 21 August 2021 Pages: 19 - 19
Risk-adapted breast cancer screening and prevention most cost-effective approach in Europe Unknown 21 August 2021 Pages: 20 - 20
Secondary fracture prevention cost saving for Medicare patients with osteoporosis Clinical study 21 August 2021 Pages: 21 - 21
Subcutaneous infliximab may be cost saving for treating rheumatoid arthritis in the UK Clinical study 21 August 2021 Pages: 22 - 22
Switch to high-dose quadrivalent influenza vaccine cost effective for elderly in Spain Clinical study 21 August 2021 Pages: 23 - 23
Systematic review finds big variation in economic burden, QOL estimates for carcinoid syndrome Clinical study 21 August 2021 Pages: 24 - 24
Systematic review: malaria control interventions appear to be cost effective Clinical study 21 August 2021 Pages: 25 - 25
Targeted therapy starting with rituximab appears the least costly for rheumatoid arthritis Clinical study 21 August 2021 Pages: 26 - 26
Treating opioid overdose in a primary care setting costs less than hospital-based care Clinical study 21 August 2021 Pages: 27 - 27
UK mental health engagement programme too costly for prisoners near release? Clinical study 21 August 2021 Pages: 28 - 28
Use and costs of unindicated preprocedural urinalysis remain high in the USA Non-clinical study 21 August 2021 Pages: 29 - 29
Vaccination against four preventable diseases in older adults good value for money in the US Non-clinical study 21 August 2021 Pages: 30 - 30
Web-based programme, Mindful Mood Boost, cost effective for depression in the USA Clinical study 21 August 2021 Pages: 31 - 31
ICER issues its final evidence report on controversial Alzheimer's drug, aducanumab News item 21 August 2021 Pages: 32 - 32
NZ's pharmac launches initiative for Māori and Pacific Peoples with type 2 diabetes News item 21 August 2021 Pages: 33 - 33
SMC accepts six new treatments for routine use on NHS Scotland News item 21 August 2021 Pages: 34 - 34
UK's Competition and Markets Authority accuses Pfizer and Flynn of illegal pricing News item 21 August 2021 Pages: 35 - 35
UK's NICE has recommended abemaciclib for advanced breast cancer in draft guidance News item 21 August 2021 Pages: 36 - 36